IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers
The Future of Cancer Immunotherapy: A Glimpse into Revolutionary Technologies Recent advancements in cancer treatment highlight the potential of immunotherapy to transform how we combat hard-to-treat cancers. A groundbreaking study from Rice University introduces an implantable “cytokine factory” that safely triggers potent immune responses, particularly against metastatic melanoma, pancreatic, and colorectal tumors. Revolutionizing Cancer Treatment … Read more